 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/14/2021 |
$106.22 |
$106.67 |
$105.58 |
$105.90 |
7.77M | | 04/15/2021 |
$105.99 |
$106.95 |
$105.62 |
$106.89 |
5.73M | | 04/16/2021 |
$107.49 |
$108.55 |
$107.14 |
$107.91 |
8.21M | | 04/19/2021 |
$107.97 |
$108.73 |
$107.12 |
$108.61 |
4.54M | | 04/20/2021 |
$108.12 |
$109.56 |
$108.05 |
$109.03 |
5.41M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid. | |
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on April 14, 2021, ABBV opened at $106.22, traded as high as $106.67 and as low as $105.58, and closed at $105.90. Trading volume was a total of 7.77M shares. On April 15, 2021, ABBV opened at $105.99, traded as high as $106.95 and as low as $105.62, and closed at $106.89. Trading volume was a total of 5.73M shares. On April 16, 2021, ABBV opened at $107.49, traded as high as $108.55 and as low as $107.14, and closed at $107.91. Trading volume was a total of 8.21M shares. On April 19, 2021, ABBV opened at $107.97, traded as high as $108.73 and as low as $107.12, and closed at $108.61. Trading volume was a total of 4.54M shares. On April 20, 2021, ABBV opened at $108.12, traded as high as $109.56 and as low as $108.05, and closed at $109.03. Trading volume was a total of 5.41M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
04/20/2021 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$109.03 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
403.54 |
|
| Dividends reinvested/share: |
$25.31 |
|
| Total return: |
339.97% |
|
| Average Annual Total Return: |
19.55% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$44,010.40 |
|
| Years: |
8.30 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
04/20/2021 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$109.03 |
|
| Dividends collected/share: |
$25.31 |
|
| Total return: |
282.52% |
|
| Average Annual Total Return: |
17.55% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$38,260.59 |
|
| Years: |
8.30 |
|
|
|
| Date |
Close |
| 04/14/2021 | $105.90 | | 04/15/2021 | $106.89 | | 04/16/2021 | $107.91 | | 04/19/2021 | $108.61 | | 04/20/2021 | $109.03 |
|
|
